Cystic Fibrosis: Exploiting Its Genetic Basis in the Hunt for New Therapies

Overview

Journal Pharmacol Ther

Specialty Pharmacology

Date 2009 Nov 12

PMID 19903491

Citations 21

Authors

James L Kreindler

Affiliations

Soon will be listed here.

Abstract

Cystic fibrosis (CF) is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR), an anion channel expressed in epithelial cells throughout the body. In the lungs, absence or dysfunction of CFTR results in altered epithelial salt and water transport eventuating in impaired mucociliary clearance, chronic infection and inflammation, and tissue damage. CF lung disease is the major cause of morbidity and mortality in CF despite the many therapies aimed at reducing it. However, recent technological advances combined with two decades of research driven by the discovery of the CFTR gene have resulted in the development and clinical testing of novel therapies aimed at the principal underlying defect in CF, thereby ushering in a new age of therapy for CF.

Citing Articles

Next-Generation Sequencing for Molecular Diagnosis of Cystic Fibrosis in a Brazilian Cohort.

Cambraia A, Junior M, Zembrzuski V, Junqueira R, Cabello P, de Cabello G Dis Markers. 2021; 2021:9812074.

PMID: 33613790 PMC: 7878085. DOI: 10.1155/2021/9812074.

Chitosan in Non-Viral Gene Delivery: Role of Structure, Characterization Methods, and Insights in Cancer and Rare Diseases Therapies.

Santos-Carballal B, Fernandez Fernandez E, Goycoolea F Polymers (Basel). 2019; 10(4).

PMID: 30966479 PMC: 6415274. DOI: 10.3390/polym10040444.

The road for survival improvement of cystic fibrosis patients in Arab countries.

Banjar H, Angyalosi G Int J Pediatr Adolesc Med. 2019; 2(2):47-58.

PMID: 30805437 PMC: 6372404. DOI: 10.1016/j.ijpam.2015.05.006.

The potential of antisense oligonucleotide therapies for inherited childhood lung diseases.

Martinovich K, Shaw N, Kicic A, Schultz A, Fletcher S, Wilton S Mol Cell Pediatr. 2018; 5(1):3.

PMID: 29411170 PMC: 5801198. DOI: 10.1186/s40348-018-0081-6.

Cystic fibrosis carriership and tuberculosis: hints toward an evolutionary selective advantage based on data from the Brazilian territory.

Bosch L, Bosch B, De Boeck K, Nawrot T, Meyts I, Vanneste D BMC Infect Dis. 2017; 17(1):340.

PMID: 28499359 PMC: 5429554. DOI: 10.1186/s12879-017-2448-z.

References

Moss R, Rodman D, Terry Spencer L, Aitken M, Zeitlin P, Waltz D . Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial. Chest. 2004; 125(2):509-21. DOI: 10.1378/chest.125.2.509. View

Knowles M, GATZY J, Boucher R . Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med. 1981; 305(25):1489-95. DOI: 10.1056/NEJM198112173052502. View

Reddy M, Quinton P . Deactivation of CFTR-Cl conductance by endogenous phosphatases in the native sweat duct. Am J Physiol. 1996; 270(2 Pt 1):C474-80. DOI: 10.1152/ajpcell.1996.270.2.C474. View

Goddard C, Ratcliff R, ANDERSON J, Glenn E, Brown S, Gill D . A second dose of a CFTR cDNA-liposome complex is as effective as the first dose in restoring cAMP-dependent chloride secretion to null CF mice trachea. Gene Ther. 1998; 4(11):1231-6. DOI: 10.1038/sj.gt.3300515. View

Armstrong D, Hook S, Jamsen K, Nixon G, Carzino R, Carlin J . Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr Pulmonol. 2005; 40(6):500-10. DOI: 10.1002/ppul.20294. View

Yew N, Zhao H, Wu I, Song A, Tousignant J, Przybylska M . Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol Ther. 2000; 1(3):255-62. DOI: 10.1006/mthe.2000.0036. View

Riordan J, Rommens J, Kerem B, Alon N, Rozmahel R, Grzelczak Z . Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989; 245(4922):1066-73. DOI: 10.1126/science.2475911. View

Quinton P, Bijman J . Higher bioelectric potentials due to decreased chloride absorption in the sweat glands of patients with cystic fibrosis. N Engl J Med. 1983; 308(20):1185-9. DOI: 10.1056/NEJM198305193082002. View

Ferrone M, Raimondo M, Scolapio J . Pancreatic enzyme pharmacotherapy. Pharmacotherapy. 2007; 27(6):910-20. DOI: 10.1592/phco.27.6.910. View

10.

Zhang L, Wang D, Fischer H, Fan P, Widdicombe J, Kan Y . Efficient expression of CFTR function with adeno-associated virus vectors that carry shortened CFTR genes. Proc Natl Acad Sci U S A. 1998; 95(17):10158-63. PMC: 21478. DOI: 10.1073/pnas.95.17.10158. View

11.

Zielenski J, Tsui L . Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet. 1995; 29:777-807. DOI: 10.1146/annurev.ge.29.120195.004021. View

12.

Howard M, Frizzell R, Bedwell D . Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations. Nat Med. 1996; 2(4):467-9. DOI: 10.1038/nm0496-467. View

13.

Serohijos A, Hegedus T, Aleksandrov A, He L, Cui L, Dokholyan N . Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function. Proc Natl Acad Sci U S A. 2008; 105(9):3256-61. PMC: 2265173. DOI: 10.1073/pnas.0800254105. View

14.

Caplen N, Alton E, Middleton P, Dorin J, Stevenson B, Gao X . Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med. 1995; 1(1):39-46. DOI: 10.1038/nm0195-39. View

15.

Anderson M, Berger H, Rich D, Gregory R, Smith A, Welsh M . Nucleoside triphosphates are required to open the CFTR chloride channel. Cell. 1991; 67(4):775-84. DOI: 10.1016/0092-8674(91)90072-7. View

16.

Harris R, NORMAN A, Payne W . The effect of pancreatin therapy on fat absorption and nitrogen retention in children with fibrocystic disease of the pancreas. Arch Dis Child. 1955; 30(153):424-7. PMC: 2011803. DOI: 10.1136/adc.30.153.424. View

17.

Walters R, Grunst T, Bergelson J, Finberg R, Welsh M, Zabner J . Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J Biol Chem. 1999; 274(15):10219-26. DOI: 10.1074/jbc.274.15.10219. View

18.

Pedemonte N, Lukacs G, Du K, Caci E, Zegarra-Moran O, Galietta L . Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J Clin Invest. 2005; 115(9):2564-71. PMC: 1190372. DOI: 10.1172/JCI24898. View

19.

Ruiz F, Clancy J, Perricone M, Bebok Z, Hong J, Cheng S . A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. Hum Gene Ther. 2001; 12(7):751-61. DOI: 10.1089/104303401750148667. View

20.

Illek B, Zhang L, Lewis N, Moss R, Dong J, Fischer H . Defective function of the cystic fibrosis-causing missense mutation G551D is recovered by genistein. Am J Physiol. 1999; 277(4):C833-9. DOI: 10.1152/ajpcell.1999.277.4.C833. View